Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Treating postoperative nausea and vomiting

a postoperative nausea and vomiting technology, applied in the direction of ester active ingredients, organic active ingredients, drug compositions, etc., can solve the problems of additional staffing and overhead costs, particularly bothersome effects, etc., and achieve the effect of reducing ponv

Inactive Publication Date: 2017-12-21
PRECONDIT LLC
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a method to reduce nausea and vomiting during anesthesia by using an opioid or analgesic to condition or desensitize receptors in the body that are involved in the reflex response to nausea and vomiting. This helps to make the anesthesia process more tolerable for patients.

Problems solved by technology

These effects are particularly bothersome after surgical procedures under general anesthesia.
There is also considerable economic impact on the facilities that treat these patients and may have to deal with additional staffing and overhead costs as a result of delayed patent discharge due to PONV.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treating postoperative nausea and vomiting
  • Treating postoperative nausea and vomiting
  • Treating postoperative nausea and vomiting

Examples

Experimental program
Comparison scheme
Effect test

example 1

Prospective Randomized Clinical Trial

Materials and Methods:

[0070]A fourteen-day, randomized, double blind, parallel group study is conducted to assess the affect of one embodiment of the present invention on PONV. The primary objective is to assess whether a statistically significant difference exists in the occurrence of PONV between a treatment group and a control group.

[0071]Prospective subjects will be recruited from the St. Vincent Women's Hospital clinic and general patient population of St. Vincent Women's Hospital or St. Vincent 86th St. Prospective subjects will complete a screening survey comprising their identifying, contact, pertinent background medical information, and screening questions for patient inclusion / exclusion criteria. Eligible subjects will be asked to review and sign an informed consent form. The study will continue to recruit participants until up to 250 subjects have been enrolled.

Inclusion Criteria

[0072]Prospective patients eligible to be included in the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
chemical stimulationaaaaaaaaaa
mechanical stimulationaaaaaaaaaa
pharmaceutical compositionsaaaaaaaaaa
Login to View More

Abstract

Methods, compositions, systems, and packaging are disclosed for reducing postoperative nausea and / or vomiting (PONV) in a human patient in need of general anesthesia for surgery. Such methods may include scheduling a surgery for the human patient, and administering to the patient one or more series of prescribed medicines for at least three successive days during a regimen immediately preceding general anesthesia. Compositions may include cholinergic receptor agonists, muscarinic receptor agonists, dopamine receptor agonists, MAO inhibitors, serotonin receptor agonists, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, selective serotonin releasing agents, serotonin-norepinephrine-dopamine reuptake inhibitors, opioids, or analgesics.

Description

PRIORITY CLAIM[0001]This application is a continuation of and claims the benefit of priority of U.S. application Ser. No. 14 / 574,858, filed Dec. 18, 2014, which is a continuation of and claims the benefit of priority of International Application Serial No. PCT / US2013 / 045884, filed Jun. 14, 2013, which claims the benefit of priority from Provisional U.S. Application Ser. No. 61 / 664,622, filed Jun. 26, 2012, each of which is hereby incorporated by reference in its entirety.BACKGROUND[0002]Nausea and vomiting are common side effects of certain pharmacologic interventions and of surgery and / or other medical procedures. These side effects can result from chemical stimulation of various receptors in the body, mechanical stimulation of the gastrointestinal tract, or both. These effects are particularly bothersome after surgical procedures under general anesthesia.[0003]Patient's perception of the quality of their anesthetic experience is strongly affected by the incidence of post-operative...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/485A61K31/27A61K31/167A61K31/198A61K31/465A61K31/405
CPCA61K31/167A61K31/485A61K31/405A61K31/465A61K31/198A61K31/27A61P1/08A61K2300/00
Inventor FLEMING, C. ANDREW
Owner PRECONDIT LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products